NCT00000647View on ClinicalTrials.gov

An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

Not specified

Study Completion Date

December 31, 1994

Conditions
HIV Infections
Interventions
DRUG

CD4-IgG

DRUG

Zidovudine

DRUG

Interferon alfa-n1

PROCEDURE

Peripheral lymphocyte infusion

PROCEDURE

Bone marrow transplant

Trial Locations (1)

20892

Natl Inst of Allergy & Infect Dis / Cln Ctr, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH